| Sputnik V effectiveness against hospitalization with COVID-19 during Omicron dominance AS Shkoda, VA Gushchin, DA Ogarkova, SV Stavitskaya, OE Orlova, ... Vaccines 10 (6), 938, 2022 | 26 | 2022 |
| Sputnik Light and Sputnik V vaccination is effective at protecting medical personnel from COVID-19 during the period of Delta variant dominance GT Sukhikh, TV Priputnevich, DA Ogarkova, AA Pochtovyi, DD Kustova, ... Vaccines 10 (11), 1804, 2022 | 12 | 2022 |
| Dynamics of SARS-CoV-2 major genetic lineages in Moscow in the context of vaccine prophylaxis VA Gushchin, AA Pochtovyi, DD Kustova, DA Ogarkova, IY Tarnovetskii, ... International Journal of Molecular Sciences 23 (23), 14670, 2022 | 11 | 2022 |
| Contamination of hospital surfaces with bacterial pathogens under the current COVID-19 outbreak AA Pochtovyi, DV Vasina, DD Kustova, EV Divisenko, NA Kuznetsova, ... International Journal of Environmental Research and Public Health 18 (17), 9042, 2021 | 11 | 2021 |
| In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB. 1.9. 1, XBB. 1.9. 3, XBB. 1.5, XBB. 1.16, XBB. 2.4, BQ. 1.1. 45, CH. 1.1, and … AA Pochtovyi, DD Kustova, AE Siniavin, IV Dolzhikova, EV Shidlovskaya, ... Vaccines 11 (10), 1533, 2023 | 7 | 2023 |
| Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus VA Gushchin, DA Ogarkova, IV Dolzhikova, OV Zubkova, IV Grigoriev, ... Frontiers in Immunology 13, 1023164, 2022 | 5 | 2022 |
| Epidemic season 2021–2022: Frequency of co-infection by respiratory viral pathogens EI Burtseva, AD Panova, LV Kolobukhina, AV Ignatjeva, ES Kirillova, ... Epidemiology and Infectious Diseases 28 (2), 67-77, 2023 | 2 | 2023 |
| Characterisation of the COVID-19 epidemic process in Moscow and search for possible determinants of the trends of the observed changes VA Gushchin, AA Pochtovyi, DD Kustova, DA Ogarkova, DA Kleymenov, ... Journal of microbiology, epidemiology and immunobiology 100 (4), 267-284, 2023 | 1 | 2023 |
| Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins EN Bykonia, DA Kleymenov, VA Gushchin, AE Siniavin, EP Mazunina, ... Vaccines 12 (4), 379, 2024 | | 2024 |
| Properties of influenza viruses that caused epidemic increases in morbidity in Russia and countries of the world during 2022–2023. The effectiveness of vaccine prophylaxis EI Burtseva, LV Kolobukhina, AD Panova, EA Mukasheva, ... Problems of Virology 69 (1), 42-55, 2024 | | 2024 |
| Characteristics of hypervirulent multi-drug resistant Klebsiella pneumoniae strains in inpatients with severe COVID-19 AE Goncharov, DV Azarov, AS Mokhov, AA Pochtovyi, DD Kustova, ... Infektsionnye Bolezni, 33-40, 2022 | | 2022 |
